chr8-144513947-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004260.4(RECQL4):c.2039T>C(p.Met680Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000334 in 1,557,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2039T>C | p.Met680Thr | missense_variant | Exon 12 of 21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.968T>C | p.Met323Thr | missense_variant | Exon 11 of 20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000534626.6 | c.407T>C | p.Met136Thr | missense_variant | Exon 3 of 8 | 5 | ENSP00000477457.1 | |||
RECQL4 | ENST00000532846.2 | c.893T>C | p.Met298Thr | missense_variant | Exon 8 of 9 | 5 | ENSP00000476551.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151820Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000370 AC: 6AN: 162116Hom.: 0 AF XY: 0.0000571 AC XY: 5AN XY: 87500
GnomAD4 exome AF: 0.0000341 AC: 48AN: 1406046Hom.: 0 Cov.: 36 AF XY: 0.0000317 AC XY: 22AN XY: 694602
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151940Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74246
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2039T>C (p.M680T) alteration is located in exon 12 (coding exon 12) of the RECQL4 gene. This alteration results from a T to C substitution at nucleotide position 2039, causing the methionine (M) at amino acid position 680 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
BP4 -
Rothmund-Thomson syndrome type 2 Uncertain:1
The RECQL4 c.2039T>C (p.Met680Thr) missense change has a maximum subpopulation frequency of 0.0090% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools predict a benign effect of this variant on protein function, but to our knowledge functional studies have not been performed. To our knowledge, this variant has not been reported in individuals with RECQL4-associated conditions. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 680 of the RECQL4 protein (p.Met680Thr). This variant is present in population databases (rs372717152, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 528958). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RECQL4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at